Ischemic Colitis Caused by Intra-Aortic Balloon Pump Counterpulsation

H El-Halawany1, A Bajwa2, M Shobassy2

  • 1Division of Gastroenterology and Hepatology, Saint Luke's Hospital of Kansas City, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA ; Internal Medicine, UMKC School of Medicine, Kansas City, MO 64108, USA ; Section of Gastroenterology/Hepatology, Temple University Hospital, 3401 N. Broad Street, Philadelphia, PA 19140, USA.

Insights

Intra-aortic balloon pump counterpulsation (IABP) can prolong life but carries risks. A case study highlights bowel ischemia from a malpositioned IABP, emphasizing the need for vigilant patient monitoring.

Area of Science:

  • Cardiology
  • Vascular Surgery
  • Critical Care Medicine

Background:

  • Intra-aortic balloon pump (IABP) counterpulsation is a life-prolonging therapy for critically ill cardiac patients.
  • Despite its benefits, IABP use is associated with significant complications.

Purpose of the Study:

  • To report a case of bowel ischemia secondary to a malpositioned IABP.
  • To underscore the importance of recognizing and monitoring for IABP-related complications.

Main Methods:

  • Case report of a 56-year-old male patient.
  • Review of clinical presentation and management following IABP placement.

Main Results:

  • The patient experienced bowel ischemia attributed to malpositioning of the intra-aortic balloon pump.
  • This complication highlights a potential risk despite the established benefits of IABP therapy.

Conclusions:

  • While IABP is valuable in critical cardiac care, awareness of potential complications like bowel ischemia is crucial.
  • Vigilant monitoring of patients undergoing IABP placement is essential to detect and manage adverse events promptly.